文献速递胸部肿瘤

体重指数(BMI)、BMI变化与小细胞肺癌和非小细胞肺癌患者总生存期:国际肺癌联盟汇总分析

Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
PubMed 文献 · J Thorac Oncol · 2019-06-01

该汇总分析基于国际肺癌联盟16项研究,纳入25,430例非小细胞肺癌(NSCLC)和2,787例小细胞肺癌(SCLC)患者,分析诊断时BMI及从成年早期至诊断时BMI变化与总生存期的关联。NSCLC中诊断时体重过轻(BMI<18.5 kg/m²;aHR=1.56;95%CI 1.43-1.70)或重度肥胖(BMI>40 kg/m²;aHR=1.09;95%CI 0.95-1.26)与更差的分期特异性预后相关,超重(25≤BMI<30 kg/m²;aHR=0.89;95%CI 0.85-0.95)或肥胖(30≤BMI≤40 kg/m²;aHR=0.86;95%CI 0.82-0.91)与生存改善相关;SCLC呈现相似模式但未达统计学显著。从成年早期至诊断时BMI下降与NSCLC(aHR=1.24;95%CI 1.2-1.3)和SCLC(aHR=1.26;95%CI 1.0-1.6)更差结局相关。

要点

  • NSCLC诊断时体重过轻(BMI<18.5 kg/m²;aHR=1.56;95%CI 1.43-1.70)与更差分期特异性生存相关。
  • NSCLC诊断时超重(25≤BMI<30 kg/m²;aHR=0.89;95%CI 0.85-0.95)或肥胖(30≤BMI≤40 kg/m²;aHR=0.86;95%CI 0.82-0.91)与生存改善相关。
  • 从成年早期至诊断时BMI下降与NSCLC(aHR=1.24;95%CI 1.2-1.3)和SCLC(aHR=1.26;95%CI 1.0-1.6)更差结局相关。

核心结论

  • 诊断时体重过轻或重度肥胖与NSCLC和SCLC独立评估中更低的分期特异性生存相关。
  • 相对于成年早期,肺癌诊断时BMI下降是预后不良的一致标志物。

研究设计与样本

  • 基于国际肺癌联盟16项研究的个体水平数据汇总分析,纳入25,430例NSCLC患者和2,787例SCLC患者。
  • 采用Cox比例风险模型计算校正风险比(aHR),并绘制校正惩罚平滑样条图评估BMI变量与肺癌总生存期的关联。

主要发现

  • NSCLC总生存期与BMI基于样条图呈推测的U形风险比关系:诊断时体重过轻(BMI<18.5 kg/m²;aHR=1.56;95%CI 1.43-1.70)或重度肥胖(BMI>40 kg/m²;aHR=1.09;95%CI 0.95-1.26)与更差的分期特异性预后相关。
  • NSCLC诊断时超重(25 kg/m²≤BMI<30 kg/m²;aHR=0.89;95%CI 0.85-0.95)或肥胖(30 kg/m²≤BMI≤40 kg/m²;aHR=0.86;95%CI 0.82-0.91)与生存改善相关。
  • SCLC呈现相似模式但未达统计学显著。
  • 与成年早期至诊断时BMI增加或稳定相比,BMI下降与NSCLC(aHR=1.24;95%CI 1.2-1.3)和SCLC(aHR=1.26;95%CI 1.0-1.6)更差结局相关。
  • BMI下降与更差结局的关联在各临床人口学亚组中一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The relationships between morbid obesity, changes in body mass index (BMI) before cancer diagnosis, and lung cancer outcomes by histology (SCLC and NSCLC) have not been well studied. METHODS: Individual level data analysis was performed on 25,430 patients with NSCLC and 2787 patients with SCLC from 16 studies of the International Lung Cancer Consortium evaluating the association between various BMI variables and lung cancer overall survival, reported as adjusted hazard ratios (aHRs) from Cox proportional hazards models and adjusted penalized smoothing spline plots. RESULTS: Overall survival of NSCLC had putative U-shaped hazard ratio relationships with BMI based on spline plots: being underweight (BMI < 18.5 kg/m2; aHR = 1.56; 95% confidence interval [CI]:1.43-1.70) or morbidly overweight (BMI > 40 kg/m2; aHR = 1.09; 95% CI: 0.95-1.26) at the time of diagnosis was associated with worse stage-specific prognosis, whereas being overweight (25 kg/m2 ≤ BMI < 30 kg/m2; aHR = 0.89; 95% CI: 0.85-0.95) or obese (30 kg/m2 ≤ BMI ≤ 40 kg/m2; aHR = 0.86; 95% CI: 0.82-0.91) was associated with improved survival. Although not significant, a similar pattern was seen with SCLC. Compared with an increased or stable BMI from the period between young adulthood until date of diagnosis, a decreased BMI was associated with worse outcomes in NSCLC (aHR = 1.24; 95% CI: 1.2-1.3) and SCLC patients (aHR=1.26 (95% CI: 1.0-1.6). Decreased BMI was consistently associated with worse outcome, across clinicodemographic subsets. CONCLUSIONS: Both being underweight or morbidly obese at time of diagnosis is associated with lower stage-specific survival in independent assessments of NSCLC and SCLC patients. In addition, a decrease in BMI at lung cancer diagnosis relative to early adulthood is a consistent marker of poor survival.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Shepshelovich D, Xu W, Lu L, et al. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium. J Thorac Oncol. 2019. PMID: 31163278. doi:10.1016/j.jtho.2019.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。